UB Paderborn / Katalog / Suche / in CDI

Circulating TP53 mutations are predictive and prognostic biomarkers in pancreatic cancer patients treated with FOLFIRINOX chemotherapy

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2021-07, Vol.21, p.S12-S13

2021

Volltextzugriff (PDF)

Better disease control rate and survival after FOLFIRINOX chemotherapy in patients with locally advanced pancreatic cancer compared to patients with metastatic disease

HPB (Oxford, England), 2020, Vol.22, p.S231-S231

2020

Volltextzugriff (PDF)

Circulating micrornas associated with the systemic immune-inflammation index and prognosis in resectable pancreatic cancer

HPB (Oxford, England), 2020, Vol.22, p.S232-S232

2020

Volltextzugriff (PDF)

Circulating cytokine levels as biomarkers for response to FOLFIRINOX chemotherapy in pancreatic cancer patients

HPB (Oxford, England), 2021, Vol.23, p.S233-S234

2021

Volltextzugriff (PDF)

Circulating TP53 Mutations Are Predictive and Prognostic Biomarkers in Pancreatic Cancer Patients Treated with FOLFIRINOX Chemotherapy

HPB (Oxford, England), 2021, Vol.23, p.S681-S681

2021

Volltextzugriff (PDF)

Pleiotropic Effects of Lipid Genes on Plasma Glucose, HbA1c, and HOMA-IR Levels

Diabetes (New York, N.Y.), 2014-09, Vol.63 (9), p.3149-3158

2014

Volltextzugriff (PDF)

Long-Term (>10 Years) Prognostic Value of Dobutamine Stress Echocardiography in a High-Risk Cohort

The American journal of cardiology, 2016-04, Vol.117 (7), p.1078-1083

2016

Volltextzugriff (PDF)

Automated characterisation of lipid core plaques in vivo by quantitative optical coherence tomography tissue type imaging

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016-12, Vol.12 (12), p.1490

2016

Volltextzugriff (PDF)

A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma

European journal of cancer (1990), 2023-03, Vol.181, p.119-134

2023

Volltextzugriff (PDF)

Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients

Cancers, 2023-08, Vol.15 (17), p.4349

2023

Volltextzugriff (PDF)

Genome-scale diversity and niche adaptation analysis of Lactococcus lactis by comparative genome hybridization using multi-strain arrays

Microbial biotechnology, 2011-05, Vol.4 (3), p.383-402

2011

Volltextzugriff (PDF)

Genotype-phenotype matching analysis of 38 Lactococcus lactis strains using random forest methods

BMC microbiology, 2013-03, Vol.13 (1), p.68-68

2013

Volltextzugriff (PDF)

FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction

European journal of cancer (1990), 2024-01, Vol.196, p.113440-113440, Article 113440

2024

Volltextzugriff (PDF)

Long-Term Prognostic Value of Dobutamine Stress Echocardiography in Diabetic Patients With Limited Exercise Capability: A 13-year follow-up study

Diabetes care, 2012-03, Vol.35 (3), p.634-639

2012

Volltextzugriff (PDF)

Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211033704-17588359211033704

2021

Volltextzugriff (PDF)

P2336Dynamic changes in non-culprit coronary atherosclerotic lesion morphology: a longitudinal OCT study

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

Prediction of 9-year cardiovascular outcomes by myocardial perfusion imaging in patients with normal exercise electrocardiographic testing

European heart journal cardiovascular imaging, 2012-11, Vol.13 (11), p.900-904

2012

Volltextzugriff (PDF)

Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography

Journal of nuclear cardiology, 2012-10, Vol.19 (5), p.907-913

2012

Volltextzugriff (PDF)

Circulating mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX

Therapeutic advances in medical oncology, 2021-08, Vol.13

2021

Volltextzugriff (PDF)

Pleiotropic Effects of Lipid Genes on Plasma Glucose, HbA^sub 1c^, and HOMA-IR Levels

Diabetes (New York, N.Y.), 2014-09, Vol.63 (9), p.3149

2014

Volltextzugriff (PDF)

15-Year outcome after normal exercise 99mTc-sestamibi myocardial perfusion imaging: What is the duration of low risk after a normal scan?

Journal of nuclear cardiology, 2012-10, Vol.19 (5), p.901-906

2012

Volltextzugriff (PDF)

15-Year outcome after normal exercise ^sup 99m^Tc-sestamibi myocardial perfusion imaging: What is the duration of low risk after a normal scan?

Journal of nuclear cardiology, 2012-10, Vol.19 (5), p.901

2012

Volltextzugriff (PDF)

Demographic Differences in Coping with Uncertainty about the Future

The Journal of social psychology, 1996-04, Vol.136 (2), p.159-164

1996

Volltextzugriff (PDF)

Cognitive predictors of social improvement in adolescents with autism spectrum-disorders

Tijdschrift voor psychiatrie, 2007, Vol.49 (2), p.65-74

2007

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Circulating TP53 mutations are predictive and prognostic biomarkers in pancreatic cancer patients treated with FOLFIRINOX chemotherapy

Better disease control rate and survival after FOLFIRINOX chemotherapy in patients with locally advanced pancreatic cancer compared to patients with metastatic disease

Circulating micrornas associated with the systemic immune-inflammation index and prognosis in resectable pancreatic cancer

Circulating cytokine levels as biomarkers for response to FOLFIRINOX chemotherapy in pancreatic cancer patients

Circulating TP53 Mutations Are Predictive and Prognostic Biomarkers in Pancreatic Cancer Patients Treated with FOLFIRINOX Chemotherapy

Pleiotropic Effects of Lipid Genes on Plasma Glucose, HbA1c, and HOMA-IR Levels

Long-Term (>10 Years) Prognostic Value of Dobutamine Stress Echocardiography in a High-Risk Cohort

Automated characterisation of lipid core plaques in vivo by quantitative optical coherence tomography tissue type imaging

A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma

Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients

Genome-scale diversity and niche adaptation analysis of Lactococcus lactis by comparative genome hybridization using multi-strain arrays

Genotype-phenotype matching analysis of 38 Lactococcus lactis strains using random forest methods

FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction

Long-Term Prognostic Value of Dobutamine Stress Echocardiography in Diabetic Patients With Limited Exercise Capability: A 13-year follow-up study

Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX

Preoperative serum ADAM12 levels as a stromal marker for overall survival and benefit of adjuvant therapy in patients with resected pancreatic and periampullary cancer

P2336Dynamic changes in non-culprit coronary atherosclerotic lesion morphology: a longitudinal OCT study

Prediction of 9-year cardiovascular outcomes by myocardial perfusion imaging in patients with normal exercise electrocardiographic testing

Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography

Circulating mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX

Pleiotropic Effects of Lipid Genes on Plasma Glucose, HbA^sub 1c^, and HOMA-IR Levels

15-Year outcome after normal exercise 99mTc-sestamibi myocardial perfusion imaging: What is the duration of low risk after a normal scan?

15-Year outcome after normal exercise ^sup 99m^Tc-sestamibi myocardial perfusion imaging: What is the duration of low risk after a normal scan?

Demographic Differences in Coping with Uncertainty about the Future

Cognitive predictors of social improvement in adolescents with autism spectrum-disorders

Suchergebnisse filtern